Physician profile
John E Moore
NPI 1639197833
$407.80
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $334 · 2020: $32.69 · 2021: $25.98 · 2022: $14.74.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $135.32 | 2019 | |
| Covidien Lp | $51.17 | 2019-2020 | |
| Biom'Up Sa | $30.34 | 2019 | |
| Abbvie INC. | $25.98 | 2021 | |
| Mallinckrodt Enterprises LLC | $22.88 | 2019 | |
| Cook Medical LLC | $21.40 | 2019 | |
| Biom'Up France Sas | $21.20 | 2020 | |
| Acera Surgical, INC. | $16.26 | 2019 | |
| Baxter Healthcare | $15.16 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.74 | 2022 | |
| Ethicon INC. | $13.58 | 2019 | |
| Davol INC. | $13.32 | 2019 | |
| Depuy Synthes Sales INC. | $13.23 | 2019 | |
| Ethicon US, LLC | $13.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.